Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2Matthias Tenbusch, Monika Wytopil, Ronja Brockhoff et al.|The Lancet Infectious Diseases|2021Cited by 133
Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2Emanuel Vogel, Matthias Tenbusch, Katharina Kocher et al.|EBioMedicine|2022Cited by 30
Heterologous prime-boost vaccination with ChAdOx1 nCoV-19 and BNT162b2 mRNAMatthias Tenbusch, Ulrike Protzer, Sofie Schumacher et al.|medRxiv|2021Cited by 5
Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2Emanuel Vogel, Matthias Tenbusch, Katharina Kocher et al.|medRxiv|2022Cited by 2